Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Works matching IS 0284-186X AND VI 49 AND IP 1 AND DT 2010
Results: 27
1
2
Five patients with malignant endocrine tumors treated with imatinib mesylate (Glivec®)
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
3
Preoperative radiotherapy in rectal signet-ring cell carcinoma - magnetic resonance imaging and treatment outcome: report of six cases.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
4
Oncolytic adenovirus treatment of a patient with refractory neuroblastoma.
- Published in:
- 2010
- By:
- Publication type:
- Letter
5
Gemcitabine and capecitabine in combination for advanced anthracycline and taxane pre-treated breast cancer patients: A phase II study.
- Published in:
- Acta Oncologica, 2010, v. 49, n. 1, p. 35, doi. 10.3109/02841860903268031
- By:
- Publication type:
- Article
6
Sarcomatoid squamous cell carcinoma of the penis.
- Published in:
- 2010
- By:
- Publication type:
- Letter
7
SiRNA-mediated IGF-1R inhibition sensitizes human colon cancer SW480 cells to radiation.
- Published in:
- Acta Oncologica, 2010, v. 49, n. 1, p. 70, doi. 10.3109/02841860903334429
- By:
- Publication type:
- Article
8
Somatic mutation of PIK3R1 gene is rare in common human cancers.
- Published in:
- 2010
- By:
- Publication type:
- Letter
9
Primary extraosseous osteosarcoma of the lung.
- Published in:
- 2010
- By:
- Publication type:
- Letter
10
Sorafenib induces partial response in metastatic medullary thyroid carcinoma.
- Published in:
- 2010
- By:
- Publication type:
- Letter
11
An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer.
- Published in:
- Acta Oncologica, 2010, v. 49, n. 1, p. 91, doi. 10.3109/02841860903246557
- By:
- Publication type:
- Article
12
Five patients with malignant endocrine tumors treated with imatinib mesylate (Glivec®).
- Published in:
- 2010
- By:
- Publication type:
- Letter
13
Chemotherapy maintenance: An option for prolonged survival in malignant peritoneal mesothelioma?
- Published in:
- 2010
- By:
- Publication type:
- Letter
14
Case studies showing clinical signs and management of cutaneous toxicity of the MEK1/2 inhibitor AZD6244 (ARRY-142886) in patients with solid tumours.
- Published in:
- 2010
- By:
- Publication type:
- Letter
15
Preoperative radiotherapy in rectal signet-ring cell carcinoma – magnetic resonance imaging and treatment outcome.
- Published in:
- Acta Oncologica, 2010, v. 49, n. 1, p. 42, doi. 10.3109/02841860903081897
- By:
- Publication type:
- Article
16
Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer.
- Published in:
- Acta Oncologica, 2010, v. 49, n. 1, p. 57, doi. 10.3109/02841860903334411
- By:
- Publication type:
- Article
17
Metastatic adamantinoma responds to treatment with receptor tyrosine kinase inhibitor.
- Published in:
- 2010
- By:
- Publication type:
- Letter
18
Targeted therapies in the treatment of GIST: Adverse events and maximising the benefits of sunitinib through proactive therapy management.
- Published in:
- Acta Oncologica, 2010, v. 49, n. 1, p. 13, doi. 10.3109/02841860903287205
- By:
- Publication type:
- Article
19
Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet.
- Published in:
- Acta Oncologica, 2010, v. 49, n. 1, p. 50, doi. 10.3109/02841860903369540
- By:
- Publication type:
- Article
20
A study of the expression of Cyclin E and its isoforms in tumor and adjacent mucosa, correlated to patient outcome in early colon cancer.
- Published in:
- Acta Oncologica, 2010, v. 49, n. 1, p. 63, doi. 10.3109/02841860903268049
- By:
- Publication type:
- Article
21
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias.
- Published in:
- 2010
- By:
- Publication type:
- Letter
22
A FOLFIRI-induced complete tumor response in a patient with FOLFOX-refractory metastatic duodenal adenocarcinoma.
- Published in:
- Acta Oncologica, 2010, v. 49, n. 1, p. 123, doi. 10.3109/02841860903081913
- By:
- Publication type:
- Article
23
Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925).
- Published in:
- Acta Oncologica, 2010, v. 49, n. 1, p. 24, doi. 10.3109/02841860903352959
- By:
- Publication type:
- Article
24
Lingual angioedema associated with everolimus.
- Published in:
- 2010
- By:
- Publication type:
- Letter
25
Matrix metalloproteinase (MMP)-7 in salivary gland cancer.
- Published in:
- Acta Oncologica, 2010, v. 49, n. 1, p. 85, doi. 10.3109/02841860903287197
- By:
- Publication type:
- Article
26
A systematic review and meta-analysis of immunochemotherapy with rituximab for B-cell non-Hodgkin's lymphoma.
- Published in:
- Acta Oncologica, 2010, v. 49, n. 1, p. 3, doi. 10.3109/02841860903150502
- By:
- Publication type:
- Article
27
Separation and identification of differentially expressed nuclear matrix proteins in breast carcinoma forming.
- Published in:
- Acta Oncologica, 2010, v. 49, n. 1, p. 76, doi. 10.3109/02841860903287213
- By:
- Publication type:
- Article